Inventor · disambiguated record
George Tachas
Also filed as: TACHAS GEORGE
16 granted patents·6 pending applications·33 citations·filing 2000–2024
90Inventor score
Top patents by PatentIndex Score
22 records- 0181US8623836B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionTACHAS GEORGE·Filed 2010·Granted Jan 7, 2014·5 cites·25 claims
- 0278US8759314B2Methods for treating multiple sclerosis using antisense oligonucleotidesKLINGER ETY·Filed 2013·Granted Jun 24, 2014·6 cites·31 claims
- 0377US9084770B2Modulation of insulin like growth factor I receptor expression in cancerTACHAS GEORGE·Filed 2009·Granted Jul 21, 2015·2 cites·21 claims
- 0477US2024392301A1Therapeutic uses and methodsANTISENSE THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0576US9717778B2Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2013·Granted Aug 1, 2017·3 cites·21 claims
- 0676US8299039B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionTACHAS GEORGE·Filed 2004·Granted Oct 30, 2012·9 cites·22 claims
- 0774US8765700B2Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditionsTACHAS GEORGE·Filed 2005·Granted Jul 1, 2014·2 cites·14 claims
- 0873US8415314B2Methods for treating multiple sclerosis using antisense oligonucleotidesKLINGER ETY·Filed 2009·Granted Apr 9, 2013·2 cites·33 claims
- 0968US7501400B1Inhibition of gastric acid production and/or secretionTACHAS GEORGE·Filed 2000·Granted Mar 10, 2009·4 cites·13 claims
- 1064US2022047679A1Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 1163US11976281B2Therapeutic uses and methodsANTISENSE THERAPEUTICS LTD·Filed 2019·Granted May 7, 2024·0 cites·13 claims
- 1261US9371530B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionANTISENSE THERAPEUTICS LTD·Filed 2013·Granted Jun 21, 2016·0 cites·7 claims
- 1359US9885048B2Method for reducing circulating leukocytes in a human subjectANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Feb 6, 2018·0 cites·8 claims
- 1456US9988635B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Jun 5, 2018·0 cites·12 claims
- 1554US2013323196A1Method for mobilizing stem and/or progenitor cellsTACHAS GEORGE·Filed 2011·Application pending·0 cites
- 1652US11041156B2Mobilizing leukemia cellsANTISENSE THERAPEUTICS LTD·Filed 2018·Granted Jun 22, 2021·0 cites·16 claims
- 1751US2016129089A1Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2014·Application pending·0 cites
- 1850US8637484B2Modulation of growth hormone receptor expression and insulin-like growth factor expressionANTISENSE THERAPEUTIC LTD·Filed 2012·Granted Jan 28, 2014·0 cites·10 claims
- 1950US2022296631A1Methods for treating muscular dystrophy using inhibitory oligonucleotides to cd49dANTISENSE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2048US9821034B2Combination therapyANTISENSE THERAPEUTICS LTD·Filed 2016·Granted Nov 21, 2017·0 cites·21 claims
- 2146US11891606B2Methods for treating multiple sclerosis using antisense oligonucleotidesANTISENSE THERAPEUTICS LTD·Filed 2018·Granted Feb 6, 2024·0 cites·21 claims
- 2244US2015344890A1Modulation of Insulin Like Growth Factor I Receptor Expression in CancerANTISENSE THERAPEUTICS LTD·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →